Sirnaomics Future Growth
Future criteria checks 2/6
Sirnaomics is forecast to grow revenue at 58.2% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 34.9% |
Revenue growth rate | 58.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Dec 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 161 | N/A | -138 | N/A | 1 |
12/31/2025 | 70 | N/A | -159 | N/A | 1 |
12/31/2024 | 2 | -124 | -120 | -126 | 1 |
12/31/2023 | 0 | -79 | -70 | -70 | N/A |
9/30/2023 | 0 | -82 | -82 | -76 | N/A |
6/30/2023 | N/A | -84 | -93 | -82 | N/A |
3/31/2023 | N/A | -86 | -100 | -85 | N/A |
12/31/2022 | N/A | -88 | -108 | -89 | N/A |
9/30/2022 | 0 | -230 | -103 | -87 | N/A |
6/30/2022 | N/A | -223 | -96 | -83 | N/A |
3/31/2022 | N/A | -218 | -80 | -70 | N/A |
12/31/2021 | N/A | -213 | -63 | -57 | N/A |
9/30/2021 | 0 | -60 | -49 | -44 | N/A |
12/31/2020 | N/A | -44 | -21 | -19 | N/A |
12/31/2019 | 0 | -16 | -16 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2257's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 2257's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 2257's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2257's revenue (58.2% per year) is forecast to grow faster than the Hong Kong market (8.1% per year).
High Growth Revenue: 2257's revenue (58.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2257's Return on Equity is forecast to be high in 3 years time